SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001662252-18-000031
Filing Date
2018-02-15
Accepted
2018-02-14 17:38:24
Documents
1
Period of Report
2017-12-31
Effectiveness Date
2018-02-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q rchant10q.htm NT 10-Q 17211
  Complete submission text file 0001662252-18-000031.txt   18312
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: NT 10-Q | Act: 34 | File No.: 000-54767 | Film No.: 18614204
SIC: 2834 Pharmaceutical Preparations